Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Expert Review of Anticancer Therapy
|
May 5, 2022
The use of real-world evidence to support FDA post-approval study requirements for oncology drugs
Marjorie E Zettler
Cancers
|
June 27, 2024
Dose Optimization of Targeted Therapies for Oncologic Indications
Marjorie E Zettler
Expert Review of Anticancer Therapy
|
January 20, 2022
The RACE for children act at one year: progress in pediatric development of molecularly targeted oncology drugs
Marjorie E Zettler
Targeted Oncology
|
July 21, 2023
FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications
Marjorie E Zettler
Cancers
|
April 14, 2025
Assessment of Objective Response Rate by Investigator vs. Blinded Independent Central Review in Pivotal Trials of Oncology Drugs for Solid Tumor Indications
Marjorie E Zettler
The New England Journal of Medicine
|
July 25, 2020
Randomization versus Real-World Evidence
Ajeet Gajra, Marjorie E Zettler, Bruce A Feinberg
Experimental and Clinical Cardiology
|
January 26, 2011
Augmented cell cycle protein expression and kinase activity in atherosclerotic rabbit vessels
Marjorie E Zettler, Michele A Merchant, Grant N Pierce
BMJ Open
|
October 7, 2021
Impact of social determinants of health on cancer care: a survey of community oncologists
Marjorie E Zettler, Bruce A Feinberg, Yolaine Jeune-Smith, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 7, 2004
Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins
Marjorie E Zettler, Michele A Prociuk, J Alejandro Austria, et al.
JCO Oncology Practice
|
April 22, 2021
Expanded Access and Right To Try Requests: The Community Oncologist's Experience
Marjorie E Zettler, Yolaine Jeune-Smith, Bruce A Feinberg, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Expert Review of Anticancer Therapy
|
May 5, 2022
The use of real-world evidence to support FDA post-approval study requirements for oncology drugs
Marjorie E Zettler
Cancers
|
June 27, 2024
Dose Optimization of Targeted Therapies for Oncologic Indications
Marjorie E Zettler
Expert Review of Anticancer Therapy
|
January 20, 2022
The RACE for children act at one year: progress in pediatric development of molecularly targeted oncology drugs
Marjorie E Zettler
Targeted Oncology
|
July 21, 2023
FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications
Marjorie E Zettler
Cancers
|
April 14, 2025
Assessment of Objective Response Rate by Investigator vs. Blinded Independent Central Review in Pivotal Trials of Oncology Drugs for Solid Tumor Indications
Marjorie E Zettler
The New England Journal of Medicine
|
July 25, 2020
Randomization versus Real-World Evidence
Ajeet Gajra, Marjorie E Zettler, Bruce A Feinberg
Experimental and Clinical Cardiology
|
January 26, 2011
Augmented cell cycle protein expression and kinase activity in atherosclerotic rabbit vessels
Marjorie E Zettler, Michele A Merchant, Grant N Pierce
BMJ Open
|
October 7, 2021
Impact of social determinants of health on cancer care: a survey of community oncologists
Marjorie E Zettler, Bruce A Feinberg, Yolaine Jeune-Smith, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 7, 2004
Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins
Marjorie E Zettler, Michele A Prociuk, J Alejandro Austria, et al.
JCO Oncology Practice
|
April 22, 2021
Expanded Access and Right To Try Requests: The Community Oncologist's Experience
Marjorie E Zettler, Yolaine Jeune-Smith, Bruce A Feinberg, et al.
Page
of 3